Coronary Artery Disease
Showing NaN - NaN of 74
Coronary Artery Disease, Atherosclerosis, Coronary Atherosclerosis of Native Coronary Artery Trial in Baltimore (PET/CT)
Recruiting
- Coronary Artery Disease
- +2 more
- PET/CT
-
Baltimore, MarylandJohns Hopkins Hospital
Aug 8, 2023
Myocardial Infarction, Heart Failure, Systolic, Heart Valve Diseases Trial in United States (In-person cardiac rehabilitation,
Not yet recruiting
- Myocardial Infarction
- +5 more
- In-person cardiac rehabilitation
- Telehealth cardiac rehabilitation
-
San Francisco, California
- +3 more
Jun 27, 2023
Coronary Artery Disease, Ischemia Trial in Baltimore (Computed Tomography Angiography)
Active, not recruiting
- Coronary Artery Disease
- Ischemia
- Computed Tomography Angiography
-
Baltimore, MarylandJohns Hopkins Unversity School of Medicine
Jan 18, 2023
Coronary Artery Disease, Myocardial Infarction, Myocardial Ischemia Trial in Baltimore (Corrie Virtual Cardiac Rehabilitation
Not yet recruiting
- Coronary Artery Disease
- +6 more
- Corrie Virtual Cardiac Rehabilitation Program
-
Baltimore, MarylandJohns Hopkins University
Jan 17, 2023
Product Surveillance Registry
Recruiting
- Cardiac Rhythm Disorders
- +14 more
-
Birmingham, Alabama
- +394 more
Dec 19, 2022
Coronary Artery Disease, Coronary Artery Stenosis, Coronary Disease Trial in Worldwide (Absorb BVS, XIENCE)
Completed
- Coronary Artery Disease
- +3 more
- Absorb BVS
- XIENCE
-
Birmingham, Alabama
- +119 more
Jul 8, 2022
PRE-DETERMINE Cohort Study
Active, not recruiting
- Coronary Artery Disease
- +2 more
-
Anchorage, Alaska
- +89 more
Jul 19, 2022
Long Term Follow Up for CTSN Mitral Valve Repair Studies
Active, not recruiting
- Mitral Valve Insufficiency
- Coronary Artery Disease
- MV Repair
- +2 more
-
Los Angeles, California
- +23 more
Apr 22, 2022
Orsiro Sirolimus Eluting Coronary Stent System in Coronary
Active, not recruiting
- Coronary Artery Disease
- +5 more
- Orsiro DES
-
Fairhope, Alabama
- +32 more
Mar 1, 2022
Coronary Artery Disease Trial in Baltimore (Methotrexate, Colchicine, Placebo)
Completed
- Coronary Artery Disease
- Methotrexate
- +2 more
-
Baltimore, MarylandJohns Hopkins Hospital
Sep 24, 2021
Coronary Artery Disease, Human Immunodeficiency Virus Trial in Baltimore (Colchicine, Placebo)
Completed
- Coronary Artery Disease
- Human Immunodeficiency Virus
- Colchicine
- Placebo
-
Baltimore, MarylandJohns Hopkins Hospital
Sep 20, 2021
VerifyNow® Aspirin Test and PRUTest® Platelet Reactivity Tests
Active, not recruiting
- Platelet Aggregation
- Coronary Artery Disease
-
Jacksonville, Florida
- +1 more
Sep 7, 2021
Acute Myocardial Infarction, Coronary Artery Disease, Acute Coronary Syndrome Trial in Baltimore, Boston, Reading (Corrie Health
Completed
- Acute Myocardial Infarction
- +3 more
- Corrie Health Digital Platform
-
Baltimore, Maryland
- +3 more
Jul 27, 2021
Coronary Artery Disease Trial in Baltimore (Hybrid PET/CT)
Terminated
- Coronary Artery Disease
- Hybrid PET/CT
-
Baltimore, MarylandUniversity of Maryland Medical Center
May 17, 2021
CHF, Ischemic Cardiomyopathy, Coronary Artery Disease Trial in Germany, United States (Blue Egg Device)
Withdrawn
- Congestive Heart Failure
- +3 more
- Blue Egg Device
-
Los Angeles, California
- +9 more
Mar 10, 2021
Coronary Artery Disease Trial in United States (Fortify® ST, Fortify Assura® ST, Ellipse® ST family of devices)
Terminated
- Coronary Artery Disease
- Fortify® ST, Fortify Assura® ST, Ellipse® ST family of devices
-
Birmingham, Alabama
- +96 more
Jan 8, 2021
Coronary Artery Disease Trial in Worldwide (Flurpiridaz F18, 99mTechnicium (sestamibi or tetrofosmin))
Completed
- Coronary Artery Disease
- Flurpiridaz F18
- 99mTechnicium (sestamibi or tetrofosmin)
-
Mobile, Alabama
- +80 more
Nov 6, 2020
Coronary Artery Disease, Peripheral Artery Disease Trial in Baltimore (Rivaroxaban 2.5 Mg Oral Tablet, Aspirin 81 mg)
Unknown status
- Coronary Artery Disease
- Peripheral Artery Disease
- Rivaroxaban 2.5 Mg Oral Tablet
- Aspirin 81 mg
-
Baltimore, MarylandSinai Hospital of Baltimore
Oct 12, 2020
Coronary Artery Disease Trial in Worldwide (3 months of dual antiplatelet therapy (DAPT), SYNERGY Stent System)
Completed
- Coronary Artery Disease
- 3 months of dual antiplatelet therapy (DAPT)
- SYNERGY Stent System
-
Phoenix, Arizona
- +109 more
Sep 4, 2020
Human Immunodeficiency Virus, Coronary Artery Disease Trial in Baltimore (Evolocumab)
Completed
- Human Immunodeficiency Virus
- Coronary Artery Disease
-
Baltimore, MarylandJohns Hopkins University
Jul 23, 2020
Coronary Heart Disease, Coronary Artery Disease, Ischemic Heart Disease Trial in Baltimore (Explorer)
Terminated
- Coronary Heart Disease
- +2 more
- Explorer
-
Baltimore, MarylandJohns Hopkins Hospital
Jun 26, 2020
Evaluate Outcomes of Moderate to Severely Calcified Coronary
Completed
- Coronary Artery Disease
- Percutaneous Coronary Intervention
-
Little Rock, Arkansas
- +33 more
Jan 30, 2020
Atherosclerosis, Coronary Artery Disease Trial in United States (Percutaneous coronary intervention (Promus PREMIER))
Completed
- Atherosclerosis
- Coronary Artery Disease
- Percutaneous coronary intervention (Promus PREMIER)
-
Phoenix, Arizona
- +51 more
May 13, 2019